Jeffrey Robert Ajer, EVP, Chief Commercial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 7,318 shares at $78.47 ($557K) on 2020-03-25, disclosed to the SEC on 2020-03-26.
Seasonal sale ($557k) by EVP, Chief Commercial Officer — this insider has traded BMRN in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.36 | 2,041 | $152K | 27.2% |
| 2 | $74.36 | 2,041 | $152K | 27.2% |
| 3 | $78.47 | 1,618 | $127K | 22.8% |
| 4 | $78.47 | 1,618 | $127K | 22.8% |
| Total | $76.18 avg | 7,318 | $557K | 100% |
| Filing → |
| NKTR | SELL | 2023-09-20 | $3K | — | Filing → |
| BMRN | SELL | 2023-08-17 | $450K | — | Filing → |
| BMRN | SELL | 2023-01-27 | $11.3M | — | Filing → |